Pharmacokinetics and Safety of Chiglitazar, a Peroxisome Proliferator‐Activated Receptor Pan‐Agonist, in Patients < 65 and ≥ 65 Years With Type 2 Diabetes
暂无分享,去创建一个
Z. Ning | Xiaojiao Li | Hong Zhang | Yanhua Ding | Jinwen Zhang | Cuiyun Li | Jia Yu | Min Wu | Jingrui Liu | Qianqian Li | Xiaoxue Zhu | Xiaoxue Zhu